Trademark: 79180333
Word
T-TRACK
Status
Dead
Status Code
709
Status Date
Friday, July 14, 2023
Serial Number
79180333
Registration Number
5111637
Registration Date
Tuesday, January 3, 2017
Mark Type
4000
Filing Date
Monday, September 14, 2015
Published for Opposition
Tuesday, October 18, 2016
Cancellation Date
Friday, July 14, 2023

Trademark Owner History
MIKROGEN GmbH -
Lophius Biosciences GmbH - Original Registrant

Classifications
5 Medicines for use in treating infectious diseases and autoimmune disorders and for use in immune monitoring; pharmaceutical and veterinary preparations for use in treating infectious diseases and autoimmune disorders and for use in immune monitoring; vaccines; chemical, biochemical and biological products and preparations for medical purposes, namely, diagnostic preparations and analysis preparations for medical purposes, eukaryotic cells, cultures of microorganisms, nucleic acids, polypeptides, protein supplements comprised of cytokines, antibodies and T-cell proteins and enzymes for infectious and autoimmune disorders
1 Chemical, biochemical and biological products and preparations used in industry and science, namely, diagnostic and analysis preparations other than for medical or veterinary purposes, eukaryotic cells for scientific laboratory or medical research, cultures of microorganisms other than for medical and veterinary use, nucleic acids for laboratory use, polypeptides for laboratory use, proteins antibodies and T-cell proteins for scientific, laboratory or medical research and enzymes for industrial purposes
42 Molecular biological or biotechnological laboratory services, namely, research and development in the field of human and veterinary diagnostics and therapy identification of epitopes and identification of target structures for the development of medicines and vaccines; development of medicines, vaccines, diagnostic preparations, analysis and diagnostic apparatus and systems; development of technologies for scientific and industrial research and production, namely, T-cell-based products for diagnosis, therapy and prevention of autoimmune and infectious disorders, development of test procedures and test kits; scientific and technological services, namely, development of eukaryotic cells, microorganisms, nucleic acids, polypeptides, proteins, namely, antibodies and T-cell proteins, enzymes; development of computer programs and databases; scientific and technological analysis of cells, nucleic acids and polypeptides by means of computer programs and databases

Trademark Events
Mar 26, 2024
Total Invalidation Of Reg Ext Protection Sent To Ib
Mar 25, 2024
Invalidation Processed
Mar 14, 2024
Total Invalidation Of Reg Ext Protection Created
Jul 14, 2023
Cancelled Section 71
Feb 10, 2023
Change Of Owner Received From Ib
Jan 3, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 17, 2018
Teas Change Of Correspondence Received
Jun 29, 2018
Correction From The Ib Examined, No Action Is Needed
Jun 15, 2018
Correction Transaction Received From Ib
Nov 27, 2017
Teas Change Of Correspondence Received
Oct 23, 2017
Correction From The Ib Examined, No Action Is Needed
Sep 29, 2017
Correction Transaction Received From Ib
Apr 22, 2017
Final Decision Transaction Processed By Ib
Apr 4, 2017
Final Disposition Notice Sent To Ib
Apr 4, 2017
Final Disposition Processed
Apr 3, 2017
Final Disposition Notice Created, To Be Sent To Ib
Feb 17, 2017
Notification Of Possible Opposition - Processed By Ib
Feb 9, 2017
Change Of Name/Address Rec'd From Ib
Jan 3, 2017
Registered-Principal Register
Oct 18, 2016
Published For Opposition
Sep 28, 2016
Notification Of Possible Opposition Sent To Ib
Sep 28, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 28, 2016
Notice Of Publication
Sep 13, 2016
Law Office Publication Review Completed
Sep 9, 2016
Approved For Pub - Principal Register
Jul 21, 2016
Teas/Email Correspondence Entered
Jul 21, 2016
Correspondence Received In Law Office
Jul 19, 2016
Assigned To Lie
Jul 14, 2016
Teas Response To Office Action Received
Mar 2, 2016
Correction From The Ib Examined, No Action Is Needed
Feb 26, 2016
Correction Transaction Received From Ib
Feb 5, 2016
Refusal Processed By Ib
Jan 15, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Jan 15, 2016
Refusal Processed By Mpu
Jan 15, 2016
Application Filing Receipt Mailed
Jan 12, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Jan 11, 2016
Non-Final Action Written
Jan 11, 2016
Assigned To Examiner
Jan 11, 2016
New Application Office Supplied Data Entered
Jan 7, 2016
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24